FDA Clearance Tracker · P970003-S241
VNS Therapy System; Model 3100 Programming Software; Model 2000 Programming Wand
Last checked: Nov 20, 2026Latest source record: Sep 15, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 15, 2023
Approved
Time to decision
165 days
Received Apr 3, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970003-S241
- Device name
- VNS Therapy System; Model 3100 Programming Software; Model 2000 Programming Wand
- Applicant
- LivaNova USA, Inc.
- Applicant location
- Houston, TX
- Received
- Apr 3, 2023
- Decided
- Sep 15, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P970003
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the new Model 3100 v1.0 Programmer Software, updated M2000 v1.1.2.2 Programming Wand Firmware, and the new Digital Products Platform.
Source documents
Other decisions for LivaNova USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250013 · Decided Mar 18, 2026 · 327 days after receipt
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.